Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
ESMO Open ; 2(2): e000158, 2017.
Article in English | MEDLINE | ID: mdl-28761742

ABSTRACT

OBJECTIVE: Through the conduct of an individual-based intervention study, the main purpose of this project was to build and evaluate the required infrastructure that may enable routine practice of precision cancer medicine in the public health services of Norway, including modelling of costs. METHODS: An eligible patient had end-stage metastatic disease from a solid tumour. Metastatic tissue was analysed by DNA sequencing, using a 50-gene panel and a study-generated pipeline for analysis of sequence data, supplemented with fluorescence in situ hybridisation to cover relevant biomarkers. Cost estimations compared best supportive care, biomarker-agnostic treatment with a molecularly targeted agent and biomarker-based treatment with such a drug. These included costs for medication, outpatient clinic visits, admission from adverse events and the biomarker-based procedures. RESULTS: The diagnostic procedures, which comprised sampling of metastatic tissue, mutation analysis and data interpretation at the Molecular Tumor Board before integration with clinical data at the Clinical Tumor Board, were completed in median 18 (8-39) days for the 22 study patients. The 23 invasive procedures (12 from liver, 6 from lung, 5 from other sites) caused a single adverse event (pneumothorax). Per patient, 0-5 mutations were detected in metastatic tumours; however, no actionable target case was identified for the current single-agent therapy approach. Based on the cost modelling, the biomarker-based approach was 2.5-fold more costly than best supportive care and 2.5-fold less costly than the biomarker-agnostic option. CONCLUSIONS: The first project phase established a comprehensive diagnostic infrastructure for precision cancer medicine, which enabled expedite and safe mutation profiling of metastatic tumours and data interpretation at multidisciplinary tumour boards for patients with end-stage cancer. Furthermore, it prepared for protocol amendments, recently approved by the designated authorities for the second study phase, allowing more comprehensive mutation analysis and opportunities to define therapy targets.

2.
Acta Ophthalmol ; 91(3): 219-25, 2013 May.
Article in English | MEDLINE | ID: mdl-22429721

ABSTRACT

PURPOSE: Storage time for donor corneas in Optisol GS is limited compared to Eye Bank Organ Culture (EBOC). We here examine the epithelium on donor corneoscleral rims after primary storage in Optisol GS and subsequent incubation in EBOC. METHODS: Morphology was monitored by light and electron microscopy, expression of phenotypic and genotypic markers by immunohistochemistry and RT-PCR and changes in oxidative lipid and DNA damage by ELISA and COMET assay. RESULTS: A prominent loss of cells was observed after storage in Optisol GS. After maintenance in EBOC, spreading apical cells were Occludin(+) , while the staining for E-cadherin and Connexin-43 was less intense. There were an upregulation of Occludin and a downregulation of E-cadherin and Connexin-43. Eye Bank Organ Culture was associated with an ongoing proliferative activity and a downregulation of putative progenitor/stem cell marker ABCG2 and p63. Staining for 8-OHdG and Caspase-3 did not increase, while levels of malondialdehyde and number of DNA strand breaks and oxidized bases increased. CONCLUSIONS: This dual procedure should be pursued as an option to increase the storage time and the pool of available donor corneas. The observed downregulation of markers associated with stemness during EBOC is relevant considering the potential use of donor epithelium in the treatment of ocular surface disorders.


Subject(s)
Chondroitin Sulfates/therapeutic use , Cornea , Cryopreservation/methods , Culture Media, Serum-Free , Dextrans/therapeutic use , Eye Banks/methods , Gentamicins/therapeutic use , Organ Preservation Solutions/therapeutic use , Organ Preservation/methods , Biomarkers/metabolism , Cell Proliferation , Comet Assay , Complex Mixtures/therapeutic use , DNA Damage , Enzyme-Linked Immunosorbent Assay , Epithelium, Corneal/metabolism , Epithelium, Corneal/ultrastructure , Female , Humans , In Situ Nick-End Labeling , Lipid Peroxidation , Lipid Peroxides/genetics , Lipid Peroxides/metabolism , Male , Middle Aged , Organ Culture Techniques , Oxidative Stress , Reverse Transcriptase Polymerase Chain Reaction , Time Factors , Tissue Donors
3.
Mol Vis ; 18: 1604-8, 2012.
Article in English | MEDLINE | ID: mdl-22736949

ABSTRACT

PURPOSE: Lipid peroxidation content was measured in an organ culture medium after one-week storage of human donor corneas. Moreover, the effects of the medium on oxidative stress, antioxidant capacity, and the proliferation of cultured human corneal cells were studied. METHODS: The medium was sampled from the upper and lower halves of storage vials and from controls (n=42). Malondialdehyde (MDA) was measured by high pressure liquid chromatography (HPLC). Cultured human corneal epithelium (CRL-11515) was exposed to different medium samples and monitored for changes in MDA (enzyme-linked immunosorbent assay [ELISA]), total antioxidant capacity (antioxidant assay kit), and proliferation (Ki-67). RESULTS: A significant increase in MDA was observed in the organ culture medium in the lower level of storage vials. The addition of this fraction to cultured cells increased MDA significantly after 3 days, and the medium from both levels significantly increased MDA after 7 days. The medium from both levels significantly decreased the total antioxidant capacity of the cells but did not affect proliferative activity. CONCLUSIONS: An oxidative gradient with an evident biologic effect is established in the medium in vials during organ culture of human donor corneas. Donor tissue stored at the bottom or in lower levels of such vials is exposed to a significant amount of oxidative stress.


Subject(s)
Culture Media, Conditioned/pharmacology , Epithelium, Corneal/metabolism , Tissue Culture Techniques , Antibodies/pharmacology , Antioxidants/metabolism , Cell Proliferation/drug effects , Cell Survival/drug effects , Chromatography, High Pressure Liquid , Enzyme-Linked Immunosorbent Assay , Epithelium, Corneal/cytology , Epithelium, Corneal/drug effects , Humans , Ki-67 Antigen/metabolism , Lipid Peroxidation/drug effects , Malondialdehyde/analysis , Oxidative Stress/drug effects , Tissue Banks
4.
Invest Ophthalmol Vis Sci ; 52(12): 8592-7, 2011 Nov 04.
Article in English | MEDLINE | ID: mdl-21969298

ABSTRACT

PURPOSE: The purpose of this study was to establish the alterations of oxidative stress-related markers in keratoconus (KC) corneas. METHODS: A total of 6 healthy and 11 ectatic corneas (7 KC and 4 post-LASIK) were studied. Different oxidative stress-related markers were determined to assess their implication in the KC pathophysiology. Total antioxidant capacity and total nitrites present in the samples were assayed. Furthermore, lipid peroxidation products and the glutathione contents were determined, together with 4-hydroxynonenal (4-HNE) immunohistochemistry, to establish the relationship between KC and oxidative stress. RESULTS: The antioxidant capacity and glutathione content in KC corneas were decreased significantly when compared with healthy corneas. Moreover, the total nitrites and lipid peroxidation were significantly elevated in the corneas with KC when compared with the controls. There was a statistically significant difference in the amount of HNE-positive cells in KC corneas when compared with healthy corneas by immunohistochemistry. Post-LASIK ectatic corneas and KC corneas showed similar results. CONCLUSIONS: The increased levels of oxidative stress markers and the decreased antioxidant capacity and antioxidant defenses in KC corneas, as well as in the post-LASIK ectatic corneas, indicate that oxidative stress might be involved in the development of this disease and may provide new insights for its prevention and treatment in the future.


Subject(s)
Antioxidants/metabolism , Keratoconus/metabolism , Keratoconus/physiopathology , Lipid Peroxidation/physiology , Oxidative Stress/physiology , Adult , Aldehydes/metabolism , Biomarkers/metabolism , Dilatation, Pathologic/metabolism , Dilatation, Pathologic/physiopathology , Female , Glutathione/metabolism , Humans , Keratoconus/surgery , Keratomileusis, Laser In Situ , Male , Middle Aged , Nitrites/metabolism
5.
Eur J Ophthalmol ; 21(4): 427-33, 2011.
Article in English | MEDLINE | ID: mdl-21038308

ABSTRACT

PURPOSE: Bevacizumab is currently used as an intravitreal agent in the treatment of inflammatory-associated eye diseases. The aim of the current study is to explore the effects of the intravitreal injection of bevacizumab on aqueous humour cytokines and chemokines in an experimental uveitis model. METHODS: Endotoxin-induced uveitis was induced in rats by footpad injections. Bevacizumab was administered by intravitreal injection (75 µg in 3-µL samples) and different chemokine and cytokine proteins were quantified in aqueous humor. RESULTS: Intravitreal administration of bevacizumab led to a several-fold increase of RANTES, MCP-1, and IFN-γ concentrations in aqueous humor of endotoxin-treated rats. CONCLUSIONS: Given the exacerbating effect of bevacizumab on inflammation agents and considering the increasing use of bevacizumab as an off-label intravitreal agent, care should be taken if an underlying inflammatory disease is present.


Subject(s)
Angiogenesis Inhibitors/administration & dosage , Antibodies, Monoclonal, Humanized/administration & dosage , Aqueous Humor/metabolism , Cytokines/metabolism , Disease Models, Animal , Uveitis/drug therapy , Animals , Bevacizumab , Chemokine CCL2/metabolism , Chemokine CCL5/metabolism , Enzyme-Linked Immunosorbent Assay , Interferon-gamma/metabolism , Intravitreal Injections , Lipopolysaccharides , Male , Rats , Rats, Inbred Lew , Uveitis/chemically induced , Uveitis/metabolism , Vascular Endothelial Growth Factor A/antagonists & inhibitors
6.
Ocul Immunol Inflamm ; 18(3): 208-15, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20482400

ABSTRACT

PURPOSE: To compare histopathological and biochemical effects of the anti-TNF-alpha drugs adalimumab and infliximab in a uveitis experimental model. METHODS: Histopathological evaluation was performed 24 h after endotoxin (200 microg into the footpad) and drug administration, as well as biochemical analysis of oxidative stress-related markers in the aqueous humor. RESULTS: Severe inflammation was found in rat anterior chamber of the eye 24 h after endotoxin. Only infliximab administration partially prevented the endotoxin-induced disruption of the blood-aqueous barrier, as well as the increase in Rantes and MCP-1 concentration in aqueous humor. Both drugs ameliorated the histopathological score after endotoxin. Biochemical analysis revealed that both drugs protected against endotoxin-induced oxidative stress, restoring all markers to control levels, except infliximab, which failed to restore GSH concentration. CONCLUSIONS: Both anti-TNF-alpha drugs were effective in reducing histopathological inflammation but their mechanism of action appears to be different.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Uveitis/drug therapy , Adalimumab , Animals , Anti-Inflammatory Agents/pharmacokinetics , Anti-Inflammatory Agents/therapeutic use , Antibodies, Monoclonal/pharmacokinetics , Antibodies, Monoclonal, Humanized , Aqueous Humor/cytology , Aqueous Humor/metabolism , Blood-Aqueous Barrier/physiology , Cells, Cultured , Disease Models, Animal , Infliximab , Male , Oxidative Stress/drug effects , Rats , Rats, Inbred Lew , Time Factors , Treatment Outcome , Uveitis/metabolism , Uveitis/pathology
7.
Graefes Arch Clin Exp Ophthalmol ; 248(7): 985-90, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20213480

ABSTRACT

BACKGROUND: The pathophysiology of the early events leading to diabetic retinopathy is not fully understood. It has been suggested that Inflammatory processes are involved in the development of the disease; however, the concentrations of tissue retinal inflammatory mediators and their possible alteration in diabetic retinopathy have not been described. The aim of this work was to study T-helper cell cytokine and chemokine profiles, and tyrosine nitration in retinal tissue of diabetic rats. METHODS: Cytokines (interleukin IL-1a, IL-1b, IL-2, IL-4, IL-6, IL-10, TNFa, GM-CSF, IFN-g), chemokines (MIP-1a, MIP-2, MIP-3a, MCP-1, GRO/KC, RANTES, Fractalkine), and tyrosine nitration were measured in retinal homogenate obtained from Long-Evans rats after 5 months of experimental diabetes. RESULTS: The T-helper type 1 cytokines IL-2 and INF-gamma, in addition to NO production (measured as nitrotyrosine), were found to be significantly elevated in diabetic rat retina homogenates. None of the other cytokines and chemokines studied were affected by the diabetic condition. CONCLUSIONS: Immunoregulatory cytokines belonging to the Th-1 group (IL-2 and IFN-gamma) were increased in the retina of experimental diabetic rats. Moreover, the nitrotyrosine formation (as an expression of increased NO production) was significantly elevated in the diabetic retina, supporting the concept of an inflammatory element in the development of diabetic retinopathy.


Subject(s)
Diabetic Retinopathy/immunology , Diabetic Retinopathy/metabolism , Interferon-gamma/metabolism , Interleukin-2/metabolism , Retina/metabolism , Animals , Cataract/immunology , Cataract/metabolism , Chemokines/metabolism , Diabetes Mellitus, Experimental/immunology , Diabetes Mellitus, Experimental/metabolism , Disease Models, Animal , Interleukin-10/metabolism , Interleukin-1alpha/metabolism , Interleukin-1beta/metabolism , Interleukin-4/metabolism , Interleukin-6/metabolism , Interleukin-8/metabolism , Male , Nitric Oxide/metabolism , Rats , Rats, Long-Evans , Retina/immunology , T-Lymphocytes, Helper-Inducer/immunology , T-Lymphocytes, Helper-Inducer/metabolism , Tumor Necrosis Factor-alpha/metabolism , Tyrosine/analogs & derivatives , Tyrosine/metabolism
8.
Curr Eye Res ; 34(11): 928-38, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19958109

ABSTRACT

PURPOSE: To assess the effect of docosahexanoic acid (DHA) and lutein (both compounds with anti-inflammatory and antioxidant properties) on experimental diabetic retinopathy. METHODS: Male Wistar rats were studied: non-diabetic controls, untreated diabetic controls, and diabetic rats were treated with DHA and lutein or the combination of DHA + insulin and lutein + insulin for 12 weeks. Oxidative stress and inflammatory markers, apoptosis, and functional tests were studied to confirm biochemical and functional changes in the retina of diabetic rats. Malondialdehyde (MDA), glutathione concentrations (GSH), and glutathione peroxidase activity (GPx) were measured as oxidative stress markers. TUNEL assay and caspase-3 immunohistochemistry and electroretinogram were performed. RESULTS: Diabetes increases oxidative stress, nitrotyrosine concentrations, and apoptosis in the retina. At 12 weeks after onset of diabetes, total thickness of retinas of diabetic rats was significantly less than that in control rats. Specifically, the thickness of the outer and inner nuclear layers was reduced significantly in diabetic rats and demonstrated a loss of cells in the GCL. These retinal changes were avoided by the administration of insulin and DHA and lutein alone or in combination with insulin. Impairment of the electroretinogram (b-wave amplitude and latency time) was observed in diabetic rats. DHA and lutein prevented all these changes even under hyperglycemic conditions. CONCLUSIONS: Lutein and DHA are capable of normalizing all the diabetes-induced biochemical, histological, and functional modifications. Specifically, the cell death mechanisms involved deserve further studies to allow the proposal as potential adjuvant therapies to help prevent vision loss in diabetic patients.


Subject(s)
Diabetes Mellitus, Experimental/prevention & control , Diabetic Retinopathy/prevention & control , Docosahexaenoic Acids/pharmacology , Lutein/pharmacology , Retina/drug effects , Retina/physiopathology , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Antioxidants/pharmacology , Apoptosis , Biomarkers/metabolism , Blood Glucose/analysis , Caspase 3/metabolism , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/physiopathology , Diabetic Retinopathy/metabolism , Diabetic Retinopathy/physiopathology , Drug Therapy, Combination , Electroretinography , Enzyme-Linked Immunosorbent Assay , Fluorescent Antibody Technique, Indirect , Glutathione/metabolism , Glutathione Peroxidase/metabolism , In Situ Nick-End Labeling , Insulin/pharmacology , Male , Malondialdehyde/metabolism , Oxidative Stress , Rats , Rats, Wistar , Tyrosine/analogs & derivatives , Tyrosine/metabolism
9.
Ophthalmic Res ; 41(1): 28-35, 2009.
Article in English | MEDLINE | ID: mdl-18852495

ABSTRACT

AIMS: To study the histopathological, biochemical and functional effects of intravitreal bevacizumab on the rat eye, with special emphasis on its immediate pro-inflammatory features eventually associated with cellular oxidative burden. METHODS: Histopathological evaluation was performed 24 h, 1 and 4 weeks after bevacizumab (75 microg/rat eye) or saline intravitreal injection, as well as biochemical analysis of oxidative stress-related markers and electroretinograms. RESULTS: Bevacizumab induces a transient inflammatory reaction together with a modification of the b-wave amplitude and latency of the electroretinogram. No changes were observed in any of the oxidative stress markers studied at any time after injection. CONCLUSION: Intravitreal bevacizumab injection per se generates an immediate, transient and mild inflammation of the rat eye, which is not associated with oxidative stress in ocular tissues.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Antibodies, Monoclonal/pharmacology , Eye/drug effects , Analysis of Variance , Animals , Antibodies, Monoclonal, Humanized , Bevacizumab , Cell Count/methods , Chromatography, High Pressure Liquid/methods , Electroretinography/methods , Glutathione Peroxidase/metabolism , Male , Malondialdehyde/metabolism , Ocular Physiological Phenomena/drug effects , Oxidative Stress/drug effects , Rats , Rats, Wistar , Reaction Time/drug effects , Spectrophotometry/methods , Time Factors
10.
Free Radic Res ; 42(7): 613-7, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18608516

ABSTRACT

The aim of this study was to test the effect of lipoic acid treatment on the retina after a short diabetic insult. Diabetes was induced by alloxan and mice were divided into sub-groups; control, diabetic, diabetic+insulin and all groups received+/-lipoic acid (100 mg/kg body weight) for 3 weeks. GSH content, MDA concentration, GPx activity were measured and electroretinograms (ERG) were recorded. Early administration of lipoic acid to diabetic mice prevented the statistically significant decreases of GSH content and GPx activity and normalized MDA concentration. Moreover, lipoic acid restored electroretinogram b-wave amplitude of diabetic animals to control values. Lipoic acid has a protective effect on the diabetic retina.


Subject(s)
Antioxidants/administration & dosage , Diabetes Mellitus, Experimental/drug therapy , Diabetic Retinopathy/prevention & control , Oxidative Stress/drug effects , Retina/drug effects , Thioctic Acid/administration & dosage , Animals , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/metabolism , Diabetic Retinopathy/etiology , Diabetic Retinopathy/metabolism , Drug Administration Schedule , Electroretinography , Glutathione/metabolism , Glutathione Peroxidase/metabolism , Hypoglycemic Agents/pharmacology , Insulin/pharmacology , Male , Malondialdehyde/metabolism , Mice , Retina/enzymology , Retina/metabolism
11.
Alcohol Alcohol ; 43(3): 254-60, 2008.
Article in English | MEDLINE | ID: mdl-18304993

ABSTRACT

AIMS: Ethanol consumption originates a wide spectrum of disorders, including alteration of visual function. Oxidative stress is included among the mechanisms by which alcohol predisposes nervous tissue to injury. Retina, which is the neurosensorial eye tissue, is particularly sensitive to oxidative stress. METHODS: In this study we analyze the effect of long-term alcohol consumption on oxidative stress parameters of the rat retina, and its correlation to retinal function, as well as to the expression of the antiapoptotic protein Bcl-2. We also study the protective effect of ebselen, a synthetic selenoorganic antioxidant. RESULTS: Herein we show that ethanol has a toxic effect on rat retina associated with oxidative stress. Decreases in retina glutathione concentration and increases in malondialdehyde content in whole eye homogenate significantly correlate with ERG b-wave decrease and Bcl-2 overexpression. We also show how ebselen is able to prevent all the alterations observed. CONCLUSION: Chronic ethanol consumption induces oxidative stress in rat retina associated with an impairment of ERG and Bcl-2 overexpression, suggesting a role for glial cells. All these alterations in the rat allow the proposal of an alcoholic retinopathy in this species.


Subject(s)
Ethanol/administration & dosage , Retina/drug effects , Retina/pathology , Alcoholism/complications , Alcoholism/pathology , Animals , Ethanol/toxicity , Male , Oxidative Stress/drug effects , Oxidative Stress/physiology , Rats , Rats, Sprague-Dawley , Retina/metabolism
12.
Neuroreport ; 18(8): 797-801, 2007 May 28.
Article in English | MEDLINE | ID: mdl-17471069

ABSTRACT

Malondialdehyde, reduced glutathione, glutathione peroxidase, glutathione reductase and cysteine protease cathepsins at postnatal (PN) days 2, 7, 14, 21 and 28 in controls (wt) and the retinal degeneration 1 (rd1) mouse model for retinitis pigmentosa retinas were measured to determine oxidative stress. In PN28 wt and PN2 rd1 retinas, elevated malondialdehyde and low glutathione peroxidase activity indicate higher oxidative load, despite higher reduced glutathione in PN2 rd1 retinas. This is due to physiological exposure to light and retinal vascular/neural restructuring, respectively. Compared with wt retinas, relatively high malondialdehyde at PN2 and cathepsin levels at PN14, 21 and 28 in rd1 retinas indicate that cells of the residual inner retina also contribute to the oxidative stress and retinal degeneration.


Subject(s)
Glutathione Peroxidase/metabolism , Oxidative Stress/physiology , Peptide Hydrolases/metabolism , Retina/enzymology , Retinal Degeneration , Age Factors , Animals , Animals, Newborn , Cyclic Nucleotide Phosphodiesterases, Type 6 , Gene Expression Regulation, Developmental/genetics , Gene Expression Regulation, Developmental/physiology , Malondialdehyde/metabolism , Mice , Mice, Mutant Strains , NADP/metabolism , Oxidative Stress/genetics , Phosphoric Diester Hydrolases/genetics , Retinal Degeneration/enzymology , Retinal Degeneration/pathology , Retinal Degeneration/physiopathology
13.
Neurochem Res ; 32(7): 1156-62, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17401664

ABSTRACT

The effects of MDMA administration on oxidative stress markers in rat eye and hippocampus, and the neuroprotective effects of the antioxidant 3,4-dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran (CR-6) have been studied. MDMA effects on liver were used for comparison with those in eye and hippocampus and to test CR-6 protective effects. Another goal was to test for apoptosis in retinal cells, as it is known that happens in liver and brain. After 1 week of ecstasy administration, malondialdehyde (MDA) concentration increased, glutathione peroxidase (GPx) activity and glutathione (GSH) content decreased in liver, as previously described. MDA concentration increased and GPx activity decreased in hippocampus; whereas no change was observed in GSH concentration. MDMA decreased ocular GSH concentration and GPx activity; no change was observed in MDA concentration. The number of TUNEL-positive nuclei increased significantly in rat retinas after 1 week of MDMA administration. CR-6 normalized the modifications in liver, hippocampus and retina mentioned above.


Subject(s)
Benzopyrans/metabolism , Hippocampus/drug effects , N-Methyl-3,4-methylenedioxyamphetamine/pharmacology , Neuroprotective Agents/metabolism , Oxidative Stress , Retina/drug effects , Serotonin Agents/pharmacology , Animals , Benzopyrans/pharmacology , Glutathione/metabolism , Glutathione Peroxidase/metabolism , Hippocampus/metabolism , Humans , In Situ Nick-End Labeling , Liver/drug effects , Liver/metabolism , Male , N-Methyl-3,4-methylenedioxyamphetamine/administration & dosage , N-Methyl-3,4-methylenedioxyamphetamine/metabolism , Neuroprotective Agents/pharmacology , Rats , Rats, Wistar , Retina/metabolism , Serotonin Agents/administration & dosage , Serotonin Agents/metabolism
14.
Alcohol Clin Exp Res ; 31(3): 486-92, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17295734

ABSTRACT

BACKGROUND: Most of the previously published data suggest a role for oxidative or nitrosative stress in ethanol-induced nervous system damage. Moreover, ethanol is able to impair learning abilities in adult mammalian brain, a process suggested to be directly related to hippocampal neurogenesis. Ebselen, a synthetic compound with antioxidant properties, is able to prevent ethanol-induced impairment of neurogenesis in adult rats. The aim of the present work was to further demonstrate the ability of ebselen to prevent biochemical alterations, and preserve long-term potentiation (LTP) and learning abilities, in the hippocampus of chronic alcoholic adult rats. METHODS: Biochemical markers of oxidative stress (glutathione and malondialdehyde) were assayed in hippocampi of control rats and animals fed a liquid alcoholic diet (Lieber-De Carli) supplemented or not with ebselen. Long-term potentiation and hippocampal-dependent tests were studied in all animal groups. RESULTS: The hippocampal concentrations of glutathione and malondialdehyde were decreased and increased, respectively, in alcohol-treated animals, and did not differ from those of the control and the alcohol+ebselen groups. Long-term potentiation in hippocampal slices from ethanol-treated animals was prevented, when compared with controls, and occurred with a similar profile in control animals and in the alcohol+ebselen groups. Learning ability was tested with the Morris water maze test. Escape latencies were higher in ethanol-treated rats than in control animals or the ones treated with ethanol+ebselen. CONCLUSIONS: The results herein strongly suggest that oxidative mechanisms may underlie the hippocampal effects of ethanol in adult rats, in view of the protective effect of ebselen.


Subject(s)
Alcohol Drinking/adverse effects , Antioxidants/pharmacology , Azoles/pharmacology , Hippocampus/drug effects , Organoselenium Compounds/pharmacology , Oxidative Stress/drug effects , Animals , Glutathione/drug effects , Isoindoles , Long-Term Potentiation/drug effects , Male , Maze Learning/drug effects , Rats , Rats, Sprague-Dawley , Spatial Behavior/drug effects
15.
Proc Natl Acad Sci U S A ; 100(13): 7919-24, 2003 Jun 24.
Article in English | MEDLINE | ID: mdl-12792022

ABSTRACT

A major pathogenic mechanism of chronic alcoholism involves oxidative burden to liver and other cell types. We show that adult neurogenesis within the dentate gyrus of the hippocampus is selectively impaired in a rat model of alcoholism, and that it can be completely prevented by the antioxidant ebselen. Rats fed for 6 weeks with a liquid diet containing moderate doses of ethanol had a 66.3% decrease in the number of new neurons and a 227-279% increase in cell death in the dentate gyrus as compared with paired controls. Neurogenesis within the olfactory bulb was not affected by alcohol. Our studies indicate that alcohol abuse, even for a short duration, results in the death of newly formed neurons within the adult brain and that the underlying mechanism is related to oxidative or nitrosative stress. Moreover, these findings suggest that the impaired neurogenesis may be a mechanism mediating cognitive deficits observed in alcoholism.


Subject(s)
Alcoholism , Antioxidants/pharmacology , Ethanol/adverse effects , Hippocampus/drug effects , Animals , Antimetabolites/pharmacology , Azoles/pharmacology , Bromodeoxyuridine/pharmacology , Cell Division/drug effects , Cell Survival/drug effects , Hippocampus/pathology , Isoindoles , Microscopy, Electron , Neurons/drug effects , Neurons/pathology , Neuroprotective Agents/pharmacology , Nitrogen/metabolism , Olfactory Bulb/drug effects , Organoselenium Compounds/pharmacology , Oxidative Stress , Rats , Rats, Sprague-Dawley , Time Factors
16.
Free Radic Biol Med ; 33(5): 669-75, 2002 Sep 01.
Article in English | MEDLINE | ID: mdl-12208353

ABSTRACT

This study was aimed at examining the role of oxygen and nitrogen reactive species in a model of experimental uveitis upon intravitreal injection of bacterial endotoxin to albino New Zealand rabbits. The inflammatory response was evaluated in terms of: (i) the integrity of the blood aqueous barrier (protein and cell content in samples of aqueous humor), (ii) histopathological changes of the eyes, (iii) clinical evaluation (with a score index based on clinical symptoms), and (iv) the concentration of malondialdehyde (MDA), in aqueous humor, as a marker of oxidative stress. Betamethasone was used as reference treatment, superoxide dismutase as quencher of superoxide anion, L-N(G)-nitro-L-arginine-methyl-esther (L-NAME) and chlorpromazine as nitric oxide synthase inhibitors, and ebselen, a glutathione peroxidase mimic, as peroxynitrite reductant. All the substances were injected subconjunctivally to the rabbits immediately after the intravitreal endotoxin injection. Ebselen was the only treatment able to decrease MDA concentration to control values, exerting an effect similar to that elicited by L-NAME on the rest of the parameters tested. The data presented render ebselen a notable choice for the treatment of uveitis, with implications for clinical trials.


Subject(s)
Antioxidants/pharmacology , Azoles/pharmacology , Organoselenium Compounds/pharmacology , Reactive Nitrogen Species , Reactive Oxygen Species , Uveitis/metabolism , Animals , Anti-Inflammatory Agents/pharmacology , Chlorpromazine/pharmacology , Disease Models, Animal , Enzyme Inhibitors/pharmacology , Free Radicals , Isoindoles , Lipid Peroxidation , Malondialdehyde/pharmacology , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Rabbits , Superoxide Dismutase
SELECTION OF CITATIONS
SEARCH DETAIL
...